These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 15940558

  • 21. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
    Zhang J, Lian R, Chen Y, Wan J.
    Ren Fail; 2024 Dec; 46(2):2357743. PubMed ID: 38847502
    [Abstract] [Full Text] [Related]

  • 22. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [Abstract] [Full Text] [Related]

  • 23. Methotrexate plus leflunomide for the treatment of relapsingWegener's granulomatosis. A retrospective uncontrolled study.
    Bremer JP, Ullrich S, Laudien M, Gross WL, Lamprecht P.
    Clin Exp Rheumatol; 2010 Jun; 28(1 Suppl 57):67-71. PubMed ID: 20412706
    [Abstract] [Full Text] [Related]

  • 24. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B, Aouba A, Pagnoux C, Cohen P, Lacassin F, Guillevin L.
    Clin Exp Rheumatol; 2007 Jun; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [Abstract] [Full Text] [Related]

  • 25. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, Chen J, Lin H, Liu F, He Y, He Y, Miao L, Chen N, Li Y, Gu Y, Shi W, Hu W, Liu Z, Bao H, Zeng C, Zhou M.
    Ann Intern Med; 2015 Jan 06; 162(1):18-26. PubMed ID: 25383558
    [Abstract] [Full Text] [Related]

  • 26. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
    Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Iklé D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH, Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.
    Arthritis Rheum; 2013 Sep 06; 65(9):2441-9. PubMed ID: 23754238
    [Abstract] [Full Text] [Related]

  • 27. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
    Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.
    Medicine (Baltimore); 2007 Sep 06; 86(5):269-277. PubMed ID: 17873756
    [Abstract] [Full Text] [Related]

  • 28. Lupus nephritis in Latin American patients: 10-year results from a single medical center in Argentina.
    Vinicki JP, Paniego FM, De Rosa G, Dubinsky D, Laborde HA, Marini A, Nasswetter G.
    Lupus; 2016 Feb 06; 25(2):217-22. PubMed ID: 26296360
    [Abstract] [Full Text] [Related]

  • 29. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 30. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep 04; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 31. Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.
    Sigdel MR, Kafle MP, Shah DS.
    BMC Nephrol; 2016 Oct 07; 17(1):145. PubMed ID: 27717323
    [Abstract] [Full Text] [Related]

  • 32. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D, Rodrigues M, da Silva JAP, Inês L.
    Lupus; 2018 Jul 07; 27(8):1358-1362. PubMed ID: 29448882
    [Abstract] [Full Text] [Related]

  • 33. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S.
    Allergol Int; 2007 Jun 07; 56(2):87-96. PubMed ID: 17460438
    [Abstract] [Full Text] [Related]

  • 34. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.
    N Engl J Med; 2005 Nov 24; 353(21):2219-28. PubMed ID: 16306519
    [Abstract] [Full Text] [Related]

  • 35. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, Mathieson P, O'Donoghue D, Jayne D, Renal Association Clinical Trials Subcommittee.
    Nephron Clin Pract; 2005 Nov 24; 100(3):c92-100. PubMed ID: 15824513
    [Abstract] [Full Text] [Related]

  • 36. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.
    Das U, Dakshina Murty KV, Prasad N, Prayag A.
    Saudi J Kidney Dis Transpl; 2010 Mar 24; 21(2):372-8. PubMed ID: 20228536
    [Abstract] [Full Text] [Related]

  • 37. A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.
    Sabry A, Abo-Zenah H, Medhat T, Sheashaa H, Mahmoud K, El-Huseini A.
    Int Urol Nephrol; 2009 Mar 24; 41(1):153-61. PubMed ID: 18214709
    [Abstract] [Full Text] [Related]

  • 38. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
    Chan TM, Tse KC, Tang CS, Lai KN, Li FK.
    Lupus; 2005 Mar 24; 14(4):265-72. PubMed ID: 15864912
    [Abstract] [Full Text] [Related]

  • 39. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun 24; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 40. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
    Lê Thi Huong D, Papo T, Piette JC, Wechsler B, Blétry O, Lamas G, Baumelou A, Le Hoang P, Pennaforte JL, Valcke JC, Godeau P.
    Clin Exp Rheumatol; 1996 Jun 24; 14(1):9-16. PubMed ID: 8697666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.